Copyright Reports & Markets. All rights reserved.

Global Montelukast Drug Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Montelukast Drug

      • 1.1 Definition of Montelukast Drug
      • 1.2 Montelukast Drug Segment by Type
        • 1.2.1 Global Montelukast Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Tablet
        • 1.2.3 Chewable tablet
        • 1.2.4 Oral Granules
      • 1.3 Montelukast Drug Segment by Applications
        • 1.3.1 Global Montelukast Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Drug store
        • 1.3.4 Others
      • 1.4 Global Montelukast Drug Overall Market
        • 1.4.1 Global Montelukast Drug Revenue (2014-2025)
        • 1.4.2 Global Montelukast Drug Production (2014-2025)
        • 1.4.3 North America Montelukast Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Montelukast Drug Status and Prospect (2014-2025)
        • 1.4.5 China Montelukast Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Montelukast Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Montelukast Drug Status and Prospect (2014-2025)
        • 1.4.8 India Montelukast Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Montelukast Drug
      • 2.3 Manufacturing Process Analysis of Montelukast Drug
      • 2.4 Industry Chain Structure of Montelukast Drug

      3 Development and Manufacturing Plants Analysis of Montelukast Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Montelukast Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Montelukast Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Montelukast Drug Production and Capacity Analysis
      • 4.2 Montelukast Drug Revenue Analysis
      • 4.3 Montelukast Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Montelukast Drug Regional Market Analysis

      • 5.1 Montelukast Drug Production by Regions
        • 5.1.1 Global Montelukast Drug Production by Regions
        • 5.1.2 Global Montelukast Drug Revenue by Regions
      • 5.2 Montelukast Drug Consumption by Regions
      • 5.3 North America Montelukast Drug Market Analysis
        • 5.3.1 North America Montelukast Drug Production
        • 5.3.2 North America Montelukast Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Montelukast Drug Import and Export
      • 5.4 Europe Montelukast Drug Market Analysis
        • 5.4.1 Europe Montelukast Drug Production
        • 5.4.2 Europe Montelukast Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Montelukast Drug Import and Export
      • 5.5 China Montelukast Drug Market Analysis
        • 5.5.1 China Montelukast Drug Production
        • 5.5.2 China Montelukast Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Montelukast Drug Import and Export
      • 5.6 Japan Montelukast Drug Market Analysis
        • 5.6.1 Japan Montelukast Drug Production
        • 5.6.2 Japan Montelukast Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Montelukast Drug Import and Export
      • 5.7 Southeast Asia Montelukast Drug Market Analysis
        • 5.7.1 Southeast Asia Montelukast Drug Production
        • 5.7.2 Southeast Asia Montelukast Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Montelukast Drug Import and Export
      • 5.8 India Montelukast Drug Market Analysis
        • 5.8.1 India Montelukast Drug Production
        • 5.8.2 India Montelukast Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Montelukast Drug Import and Export

      6 Montelukast Drug Segment Market Analysis (by Type)

      • 6.1 Global Montelukast Drug Production by Type
      • 6.2 Global Montelukast Drug Revenue by Type
      • 6.3 Montelukast Drug Price by Type

      7 Montelukast Drug Segment Market Analysis (by Application)

      • 7.1 Global Montelukast Drug Consumption by Application
      • 7.2 Global Montelukast Drug Consumption Market Share by Application (2014-2019)

      8 Montelukast Drug Major Manufacturers Analysis

      • 8.1 Merck & Co.
        • 8.1.1 Merck & Co. Montelukast Drug Production Sites and Area Served
        • 8.1.2 Merck & Co. Product Introduction, Application and Specification
        • 8.1.3 Merck & Co. Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Teva
        • 8.2.1 Teva Montelukast Drug Production Sites and Area Served
        • 8.2.2 Teva Product Introduction, Application and Specification
        • 8.2.3 Teva Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Mylan
        • 8.3.1 Mylan Montelukast Drug Production Sites and Area Served
        • 8.3.2 Mylan Product Introduction, Application and Specification
        • 8.3.3 Mylan Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Glenmark Pharmaceuticals
        • 8.4.1 Glenmark Pharmaceuticals Montelukast Drug Production Sites and Area Served
        • 8.4.2 Glenmark Pharmaceuticals Product Introduction, Application and Specification
        • 8.4.3 Glenmark Pharmaceuticals Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Hikma Group
        • 8.5.1 Hikma Group Montelukast Drug Production Sites and Area Served
        • 8.5.2 Hikma Group Product Introduction, Application and Specification
        • 8.5.3 Hikma Group Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Sandoz
        • 8.6.1 Sandoz Montelukast Drug Production Sites and Area Served
        • 8.6.2 Sandoz Product Introduction, Application and Specification
        • 8.6.3 Sandoz Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Torrent Pharmaceuticals
        • 8.7.1 Torrent Pharmaceuticals Montelukast Drug Production Sites and Area Served
        • 8.7.2 Torrent Pharmaceuticals Product Introduction, Application and Specification
        • 8.7.3 Torrent Pharmaceuticals Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Lannett Company
        • 8.8.1 Lannett Company Montelukast Drug Production Sites and Area Served
        • 8.8.2 Lannett Company Product Introduction, Application and Specification
        • 8.8.3 Lannett Company Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Apotex
        • 8.9.1 Apotex Montelukast Drug Production Sites and Area Served
        • 8.9.2 Apotex Product Introduction, Application and Specification
        • 8.9.3 Apotex Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Dr. Reddys Laboratories
        • 8.10.1 Dr. Reddys Laboratories Montelukast Drug Production Sites and Area Served
        • 8.10.2 Dr. Reddys Laboratories Product Introduction, Application and Specification
        • 8.10.3 Dr. Reddys Laboratories Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Aurobindo Pharma
      • 8.12 Accord Healthcare
      • 8.13 Hetero
      • 8.14 Unimark
      • 8.15 Ajanta Pharma
      • 8.16 MACLEODS
      • 8.17 Jubilant Pharma
      • 8.18 Unichem Laboratories
      • 8.19 Amneal Pharmaceuticals
      • 8.20 Shanghai Anbison Lab
      • 8.21 Perrigo
      • 8.22 Cipla
      • 8.23 CSPC Ouyi Pharmaceutical

      9 Development Trend of Analysis of Montelukast Drug Market

      • 9.1 Global Montelukast Drug Market Trend Analysis
        • 9.1.1 Global Montelukast Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Montelukast Drug Regional Market Trend
        • 9.2.1 North America Montelukast Drug Forecast 2019-2025
        • 9.2.2 Europe Montelukast Drug Forecast 2019-2025
        • 9.2.3 China Montelukast Drug Forecast 2019-2025
        • 9.2.4 Japan Montelukast Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Montelukast Drug Forecast 2019-2025
        • 9.2.6 India Montelukast Drug Forecast 2019-2025
      • 9.3 Montelukast Drug Market Trend (Product Type)
      • 9.4 Montelukast Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Montelukast Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.

        The global Montelukast Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Montelukast Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Montelukast Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Montelukast Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Montelukast Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Merck & Co.
        Teva
        Mylan
        Glenmark Pharmaceuticals
        Hikma Group
        Sandoz
        Torrent Pharmaceuticals
        Lannett Company
        Apotex
        Dr. Reddys Laboratories
        Aurobindo Pharma
        Accord Healthcare
        Hetero
        Unimark
        Ajanta Pharma
        MACLEODS
        Jubilant Pharma
        Unichem Laboratories
        Amneal Pharmaceuticals
        Shanghai Anbison Lab
        Perrigo
        Cipla
        CSPC Ouyi Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Tablet
        Chewable tablet
        Oral Granules

        Segment by Application
        Hospital
        Drug store
        Others

        Buy now